Jimmunol.1501229.Full.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cells Tissue-Specific Education of Decidual NK
Tissue-Specific Education of Decidual NK Cells Andrew M. Sharkey, Shiqiu Xiong, Philippa R. Kennedy, Lucy Gardner, Lydia E. Farrell, Olympe Chazara, Martin A. This information is current as Ivarsson, Susan E. Hiby, Francesco Colucci and Ashley of September 29, 2021. Moffett J Immunol 2015; 195:3026-3032; Prepublished online 28 August 2015; doi: 10.4049/jimmunol.1501229 Downloaded from http://www.jimmunol.org/content/195/7/3026 Supplementary http://www.jimmunol.org/content/suppl/2015/08/28/jimmunol.150122 Material 9.DCSupplemental http://www.jimmunol.org/ References This article cites 44 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/195/7/3026.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 29, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 The Authors All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Tissue-Specific Education of Decidual NK Cells Andrew M. Sharkey,*,†,1 Shiqiu Xiong,*,†,1 Philippa R. -
Fertilization & Implantation Systems
Spring 2020 – Systems Biology of Reproduction Discussion Outline – Fertilization & Implantation Systems Michael K. Skinner – Biol 475/575 CUE 418, 10:35-11:50 am, Tuesday & Thursday April 16, 2020 Week 14 Fertilization & Implantation Systems Primary Papers: 1. Teperek, et al. (2016) Genome Research 26:1034. 2. Brosens, et al. (2014) Scientific Reports 4:3894. 3. Vento-Tormo, et al. (2018) Nature 563(7731):347-353. Discussion Student 9: Reference 1 above • What was the experimental design and objectives? • What impact on the developing embryo was observed? • Can sperm epigenetic alterations modify the embryo? Student 10: Reference 2 above • How do abnormal embryos influence the endometrial cells? • What transcriptional influences were observed? • How do component embryos promote a supportive uterine environment? Student 11: Reference 3 above • What was the experimental design and technology? • What maternal-fetal interface interactions were identified? • What new insights for maternal-fetal interface were found to be critical for placentation and reproductive success? Downloaded from genome.cshlp.org on March 30, 2018 - Published by Cold Spring Harbor Laboratory Press Research Sperm is epigenetically programmed to regulate gene transcription in embryos Marta Teperek,1,2,6 Angela Simeone,1,2,6 Vincent Gaggioli,1,2 Kei Miyamoto,1,2 George E. Allen,1 Serap Erkek,3,4,7 Taejoon Kwon,5 Edward M. Marcotte,5 Philip Zegerman,1,2 Charles R. Bradshaw,1 Antoine H.F.M. Peters,3,4 John B. Gurdon,1,2 and Jerome Jullien1,2 1Wellcome Trust/Cancer Research -
Human Cell Atlas Study Reveals Maternal Immune System Modifications in Early Pregnancy 14 November 2018
Human Cell Atlas study reveals maternal immune system modifications in early pregnancy 14 November 2018 many of these problems occur in the first few weeks of the pregnancy, when the placenta is formed. The fetus creates a placenta that surrounds it in the uterus to provide nutrients and oxygen. This is in contact with the mother where it implants into the lining of the uterus—known as the decidua—to create a good blood supply for the placenta. Research on the interface between mother and fetus could help answer many vital questions, including how the mother's immune system is modified to allow both mother and the developing fetus to coexist. However, until now this area has not been well studied. Credit: CC0 Public Domain To understand this area, researchers studied more than 70,000 single cells from first trimester pregnancies. Using single-cell RNA and DNA The first Human Cell Atlas study of early sequencing they identified maternal and fetal cells pregnancy in humans has shown how the function in the decidua and placenta, and found how these of the maternal immune system is affected by cells cells were interacting with one another. They from the developing placenta. Researchers from discovered that the fetal and maternal cells were the Wellcome Sanger Institute, Newcastle using signals to talk to each other, and this University and University of Cambridge used conversation enabled the maternal immune system genomics and bioinformatics approaches to map to support fetal growth. over 70,000 single cells at the junction of the uterus and placenta. This revealed how the cells Dr. -
Regulate Human Birth Weight HLA-C2 in Combination With
Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight Susan E. Hiby, Richard Apps, Olympe Chazara, Lydia E. Farrell, Per Magnus, Lill Trogstad, Håkon K. Gjessing, This information is current as Mary Carrington and Ashley Moffett of September 23, 2021. J Immunol 2014; 192:5069-5073; Prepublished online 28 April 2014; doi: 10.4049/jimmunol.1400577 http://www.jimmunol.org/content/192/11/5069 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2014/04/27/jimmunol.140057 Material 7.DCSupplemental http://www.jimmunol.org/ References This article cites 28 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/192/11/5069.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 23, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight Susan E. Hiby,*,†,1 Richard Apps,‡,x,1 Olympe Chazara,*,† Lydia E. -
Maternal Activating Kirs Protect Against Human Reproductive Failure Mediated by Fetal HLA-C2
Amendment history: Corrigendum (January 2011) Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2 Susan E. Hiby, … , Mary Carrington, Ashley Moffett J Clin Invest. 2010;120(11):4102-4110. https://doi.org/10.1172/JCI43998. Research Article Many common disorders of pregnancy are attributed to insufficient invasion of the uterine lining by trophoblast, fetal cells that are the major cell type of the placenta. Interactions between fetal trophoblast and maternal uterine NK (uNK) cells — specifically interactions between HLA-C molecules expressed by the fetal trophoblast cells and killer Ig-like receptors (KIRs) on the maternal uNK cells — influence placentation in human pregnancy. Consistent with this, pregnancies are at increased risk of preeclampsia in mothers homozygous for KIR haplotype A (KIR AA). In this study, we have demonstrated that trophoblast expresses both paternally and maternally inherited HLA-C surface proteins and that maternal KIR AA frequencies are increased in affected pregnancies only when the fetus has more group 2H LA-C genes (C2) than the mother. These data raise the possibility that there is a deleterious allogeneic effect stemming from paternal C2. We found that this effect also occurred in other pregnancy disorders (fetal growth restriction and recurrent miscarriage), indicating a role early in gestation for these receptor/ligand pairs in the pathogenesis of reproductive failure. Notably, pregnancy disorders were less frequent in mothers that possessed the telomeric end of the […] Find the latest version: https://jci.me/43998/pdf Research article Related Commentary, page 3801 Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2 Susan E. -
Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy
The Journal of Immunology Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy Philippa R. Kennedy,*,†,‡ Olympe Chazara,*,† Lucy Gardner,*,† Martin A. Ivarsson,*,† Lydia E. Farrell,*,† Shiqiu Xiong,*,†,x Susan E. Hiby,*,† Francesco Colucci,†,{ Andrew M. Sharkey,*,† and Ashley Moffett*,† Tissue-specific NK cells are abundant in the pregnant uterus and interact with invading placental trophoblast cells that transform the maternal arteries to increase the fetoplacental blood supply. Genetic case-control studies have implicated killer cell Ig-like receptor (KIR) genes and their HLA ligands in pregnancy disorders characterized by failure of trophoblast arterial transforma- tion. Activating KIR2DS1 or KIR2DS5 (when located in the centromeric region as in Africans) lower the risk of disorders when there is a fetal HLA-C allele carrying a C2 epitope. In this study, we investigated another activating KIR, KIR2DS4, and provide genetic evidence for a similar effect when carried with KIR2DS1. KIR2DS4 is expressed by ∼45% of uterine NK (uNK) cells. Similarly to KIR2DS1, triggering of KIR2DS4 on uNK cells led to secretion of GM-CSF and other chemokines, known to promote placental trophoblast invasion. Additionally, XCL1 and CCL1, identified in a screen of 120 different cytokines, were consistently secreted upon activation of KIR2DS4 on uNK cells. Inhibitory KIR2DL5A, carried in linkage disequilibrium with KIR2DS1,is expressed by peripheral blood NK cells but not by uNK cells, highlighting the unique phenotype of uNK cells compared with peripheral blood NK cells. That KIR2DS4, KIR2DS1, and some alleles of KIR2DS5 contribute to successful pregnancy suggests that activation of uNK cells by KIR binding to HLA-C is a generic mechanism promoting trophoblast invasion into the decidua. -
Unique Receptor Repertoire in Mouse Uterine NK Cells1
The Journal of Immunology Unique Receptor Repertoire in Mouse Uterine NK cells1 Hakim Yadi,*§ Shannon Burke,*§ Zofia Madeja,†§ Myriam Hemberger,†§ Ashley Moffett,‡§ and Francesco Colucci2*§ Uterine NK (uNK) cells are a prominent feature of the uterine mucosa and regulate placentation. NK cell activity is regulated by a balance of activating and inhibitory receptors, however the receptor repertoire of mouse uNK cells is unknown. We describe -herein two distinct subsets of CD3؊CD122؉ NK cells in the mouse uterus (comprising decidua and mesometrial lymphoid ag gregate of pregnancy) at mid-gestation: a small subset indistinguishable from peripheral NK cells, and a larger subset that expresses NKp46 and Ly49 receptors, but not NK1.1 or DX5. This larger subset reacts with Dolichus biflores agglutinin, a marker of uNK cells in the mouse, and is adjacent to the invading trophoblast. By multiparametric analysis we show that the phenotype of uNK cells is unique and unprecedented in terms of adhesion, activation, and MHC binding potential. Thus, the Ly49 repertoire and the expression of other differentiation markers strikingly distinguish uNK cells from peripheral NK cells, suggesting that a selection process shapes the receptor repertoire of mouse uNK cells. The Journal of Immunology, 2008, 181: 6140–6147. terine NK (uNK)3 cells are a prominent feature of the which is a transient lymphoid structure that forms between the two pregnant uterine mucosa (decidua) and are thought to layers of myometrial smooth muscle between gd 8 and gd 14 (5). U regulate endometrial remodeling, angiogenesis, and pla- Peaking in number at mid-gestation (9–10 days), uNK cells de- centation. -
Uterine NK Cells: Active Regulators at the Maternal-Fetal Interface
Uterine NK cells: active regulators at the maternal-fetal interface Ashley Moffett, Francesco Colucci J Clin Invest. 2014;124(5):1872-1879. https://doi.org/10.1172/JCI68107. Review Pregnancy presents an immunological conundrum because two genetically different individuals coexist. The maternal lymphocytes at the uterine maternal-fetal interface that can recognize mismatched placental cells are T cells and abundant distinctive uterine NK (uNK) cells. Multiple mechanisms exist that avoid damaging T cell responses to the fetus, whereas activation of uNK cells is probably physiological. Indeed, genetic epidemiological data suggest that the variability of NK cell receptors and their MHC ligands define pregnancy success; however, exactly how uNK cells function in normal and pathological pregnancy is still unclear, and any therapies aimed at suppressing NK cells must be viewed with caution. Allorecognition of fetal placental cells by uNK cells is emerging as the key maternal-fetal immune mechanism that regulates placentation. Find the latest version: https://jci.me/68107/pdf Review Uterine NK cells: active regulators at the maternal-fetal interface Ashley Moffett1,2 and Francesco Colucci2,3 1Department of Pathology and 2Centre for Trophoblast Research, Physiology Building, University of Cambridge, Cambridge, United Kingdom. 3Department of Obstetrics and Gynaecology, University of Cambridge School of Clinical Medicine, NIHR Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, United Kingdom. Pregnancy presents an immunological conundrum because two genetically different individuals coexist. The mater- nal lymphocytes at the uterine maternal-fetal interface that can recognize mismatched placental cells are T cells and abundant distinctive uterine NK (uNK) cells. Multiple mechanisms exist that avoid damaging T cell responses to the fetus, whereas activation of uNK cells is probably physiological. -
Uterine NK Cells Unique Receptor Repertoire in Mouse
Unique Receptor Repertoire in Mouse Uterine NK cells Hakim Yadi, Shannon Burke, Zofia Madeja, Myriam Hemberger, Ashley Moffett and Francesco Colucci This information is current as of September 27, 2021. J Immunol 2008; 181:6140-6147; ; doi: 10.4049/jimmunol.181.9.6140 http://www.jimmunol.org/content/181/9/6140 Downloaded from References This article cites 41 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/181/9/6140.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Unique Receptor Repertoire in Mouse Uterine NK cells1 Hakim Yadi,*§ Shannon Burke,*§ Zofia Madeja,†§ Myriam Hemberger,†§ Ashley Moffett,‡§ and Francesco Colucci2*§ Uterine NK (uNK) cells are a prominent feature of the uterine mucosa and regulate placentation. NK cell activity is regulated by a balance of activating and inhibitory receptors, however the receptor repertoire of mouse uNK cells is unknown. -
Cells Tissue-Specific Education of Decidual NK
Tissue-Specific Education of Decidual NK Cells Andrew M. Sharkey, Shiqiu Xiong, Philippa R. Kennedy, Lucy Gardner, Lydia E. Farrell, Olympe Chazara, Martin A. This information is current as Ivarsson, Susan E. Hiby, Francesco Colucci and Ashley of March 23, 2016. Moffett Downloaded from J Immunol 2015; 195:3026-3032; Prepublished online 28 August 2015; doi: 10.4049/jimmunol.1501229 http://www.jimmunol.org/content/195/7/3026 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2015/08/28/jimmunol.150122 Material 9.DCSupplemental.html References This article cites 44 articles, 22 of which you can access for free at: http://www.jimmunol.org/content/195/7/3026.full#ref-list-1 Subscriptions Information about subscribing to The Journal of Immunology is online at: at Cambridge University Library on March 23, 2016 http://jimmunol.org/subscriptions Permissions Submit copyright permission requests at: http://www.aai.org/ji/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/cgi/alerts/etoc The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 9650 Rockville Pike, Bethesda, MD 20814-3994. Copyright © 2015 The Authors All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Tissue-Specific Education of Decidual NK Cells Andrew M. Sharkey,*,†,1 Shiqiu Xiong,*,†,1 Philippa R. Kennedy,*,† Lucy Gardner,*,† Lydia E. Farrell,*,† Olympe Chazara,*,† Martin A. Ivarsson,*,† Susan E. Hiby,*,† Francesco Colucci,†,‡ and Ashley Moffett*,† During human pregnancy, fetal trophoblast cells invade the decidua and remodel maternal spiral arteries to establish adequate nutrition during gestation. -
Regulate Human Birth Weight HLA-C2 in Combination With
Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight Susan E. Hiby, Richard Apps, Olympe Chazara, Lydia E. Farrell, Per Magnus, Lill Trogstad, Håkon K. Gjessing, This information is current as Mary Carrington and Ashley Moffett of September 23, 2021. J Immunol 2014; 192:5069-5073; Prepublished online 28 April 2014; doi: 10.4049/jimmunol.1400577 http://www.jimmunol.org/content/192/11/5069 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2014/04/27/jimmunol.140057 Material 7.DCSupplemental http://www.jimmunol.org/ References This article cites 28 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/192/11/5069.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 23, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight Susan E. Hiby,*,†,1 Richard Apps,‡,x,1 Olympe Chazara,*,† Lydia E. -
Pregnancy, Parturition and Preeclampsia in Women of African
Review www.AJOG.org OBSTETRICS Pregnancy, parturition and preeclampsia in women of African ancestry Annettee Nakimuli, MBChB, MMed (Obs&Gyn); Olympe Chazara, PhD; Josaphat Byamugisha, MBChB, MMed (Obs&Gyn), PhD; Alison M. Elliott, MA, MBBS, MD, DTM&H, FRCP; Pontiano Kaleebu, MD, PhD; Florence Mirembe, MBChB, MMed (Obs&Gyn), PhD; Ashley Moffett, MA, MB, BChir, MD, MRCP, MRCPath ore than 90% of maternal deaths M worldwide occur in sub-Saharan Maternal and associated neonatal mortality rates in sub-Saharan Africa remain unac- Africa (SSA) and south Asia. These high ceptably high. In Mulago Hospital (Kampala, Uganda), 2 major causes of maternal death maternal and associated neonatal mor- are preeclampsia and obstructed labor and their complications, conditions occurring at tality rates persist despite considerable the extremes of the birthweight spectrum, a situation encapsulated as the obstetric efforts from the World Health Organi- dilemma. We have questioned whether the prevalence of these disorders occurs more zation, governments, development part- frequently in indigenous African women and those with African ancestry elsewhere in the ners, and others.1-3 The majority of these world by reviewing available literature. We conclude that these women are at greater risk deaths are related to pregnancy compli- of preeclampsia than other racial groups. At least part of this susceptibility seems in- cations that are inadequately managed dependent of socioeconomic status and likely is due to biological or genetic factors. because of a lack of access to emergency Evidence for a genetic contribution to preeclampsia is discussed. We go on to propose health care. The maternal mortality that the obstetric dilemma in humans is responsible for this situation and discuss how ratios (MMRs) of Sweden, the United parturition and birthweight are subject to stabilizing selection.